Hi-TIDe : Immunopeptidomics

Bassani-Sternberg Lab

Our focus

Our main goal is to identify clinically relevant cancer specific Human Leukocyte Antigen (HLA) ligands that will guide the development of personalized cancer immunotherapy using state of the art proteogenomics and mass-spectrometry (MS) approaches.


Our projects

DO unil bassani group projects illust.jpg

  • We develop proteogenomics and MS-based immunopeptidomics analytical and computational approaches to identify HLA ligands derived from tumor-associated proteins, mutated neoantigens, non-canonical ORFs and post translationally modified peptides.
  • We have initiated fundamental discovery work to elucidate how tumor cells present antigens and what are the bases of tumor immunogenicity in mouse and human.
  • We are investigating the differences between T cell inflamed and non-inflamed tumors in terms of antigen presentation and the antigenic landscape and how drugs modulate the immunopeptidome.
  • We have established a continuous bioinformatics pipeline called NeoDisc enabling direct and personalized identification and prediction of neoantigens by combining genomic information derived from exome-seq analysis and transcriptomics data with measured immunopeptidomics data.
  • We apply our discovery pipeline in the context of phase I clinical vaccine and adoptive T cell therapy trials at the CHUV to identify personalized neoantigens from patient tumor samples.


UNIL web teasers general.png


News @ Bassani-Sternberg Lab

Machine learning improves immunogenic neoantigen prediction

Machine learning improves immunogenic neoantigen prediction

Follow us:  


Lausanne Oncology BASSANI lab.png

Tenure Track Assistant Professor

Ludwig assistant member

Human integrated tumor immunology discovery engine (Hi-TIDe)

Department of oncology UNIL CHUV
Ludwig Institute for Cancer Research Lausanne

Head of clinical mass spectrometry unit, Center of experimental therapeutics, Lausanne University Hospital (CHUV)

Ludwig Lausanne RGB-crop461x374.jpg (Print)

Phone +41 79 900 55 30



WEB medallions Linked 150 x100-1.png

Featured Publication ------

WEB page vignette (7).png

Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
Mar-2020 | Chloe Chong, Markus Muller... Michal Bassani-Sternberg


Ch. des Boveresses 155 - CH-1066 Epalinges
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
Ludwig Cancer ResearchUniversité de LausanneCentre Hospitalier Universitaire Vaudois (CHUV)